HansBiomed Corporation (KOSDAQ:042520)

HansBiomed Revenue

HansBiomed had revenue of 30.27B KRW in the quarter ending December 31, 2025, with 52.27% growth. This brings the company's revenue in the last twelve months to 100.17B, up 24.20% year-over-year. In the fiscal year ending September 30, 2025, HansBiomed had annual revenue of 89.78B with 10.65% growth.

• Revenue (ttm): 100.17B
• Revenue Growth: +24.20%
• P/S Ratio: 4.12
• Revenue / Employee: 337.27M
• Employees: n/a
• Market Cap: 412.87B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	89.78B	8.64B	10.65%
Sep 30, 2024	81.14B	3.11B	3.98%
Sep 30, 2023	78.03B	3.57B	4.80%
Sep 30, 2022	74.46B	15.36B	25.99%
Sep 30, 2021	59.10B	-21.00B	-26.22%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 16, 2026

Data Sources Report a data error